Broad Transcriptomic Impact of Sorafenib and Its Relation to the Antitumoral Properties in Liver Cancer Cells

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the fourth most frequent cause of cancer-related mortality worldwide. While ablation, resection and orthotopic liver transplantation are indicated at an early stage of the disease, Sorafenib (Sfb) is the current most administrated first-line treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras, Laura, Rodríguez-Gil, Alfonso, Muntané, Jordi, de la Cruz, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909169/
https://www.ncbi.nlm.nih.gov/pubmed/35267509
http://dx.doi.org/10.3390/cancers14051204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909169/
https://www.ncbi.nlm.nih.gov/pubmed/35267509
http://dx.doi.org/10.3390/cancers14051204

Ejemplares similares